Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

47,931 stories, page 62 of 799

Advanced search

🌍Oct 23discoverynews.google.comTier 3 · Aggregated media

fda approved weight loss drugs 2018

www.polskieradio.plOriginal source

🌍Oct 23discoverynews.google.comTier 3 · Aggregated media

fda approved weight loss drugs 2018

www.polskieradio.plOriginal source

🌍Oct 23discoverynews.google.comTier 3 · Aggregated media

fda concerns unapproved glp-1 drugs weight loss 2026

BusinessWorld OnlineOriginal source

🌍Oct 23discoverynews.google.comTier 3 · Aggregated media

HanAll Biopharma Wins First New Drug Approval in China; Batoclimab Royalty Era Begins

BigGo FinanceOriginal source

🌍Oct 23discoverynews.google.comTier 3 · Aggregated media

Quandela Expands Global Partnerships with KRIBB for Quantum Biotech and FPT Corporation in Vietnam

Quantum Computing ReportOriginal source

🌍Oct 23discoverynews.google.comTier 3 · Aggregated media

fda concerns unapproved glp 1 drugs weight loss summary

emyOriginal source

🌍Oct 23discoverynews.google.comTier 3 · Aggregated media

2026 fda approved weight loss drug retatrutide approval status

BusinessWorld OnlineOriginal source

🌍Oct 23discoverynews.google.comTier 3 · Aggregated media

hims faces legal action as fda restricts compounded weight-loss drugs

www.polskieradio.plOriginal source

🌍Oct 23discoverynews.google.comTier 2 · Trade media

US Treasury moves to curb investments in China's biotech industry

FirstWord PharmaOriginal source

🌍Oct 23discoverynews.google.comTier 3 · Aggregated media

new weight loss pill fda approved

www.polskieradio.plOriginal source

🇯🇵Oct 23Researchjsmo.or.jpTier 2 · Direct publisher

【ご案内】2027 Taiwan Summit of Medical Oncology (TSMO 2027)

Japanese Society of Medical OncologyOriginal source

🌍Oct 23discoverynews.google.comTier 3 · Aggregated media

new fda approved weight loss drugs

www.polskieradio.plOriginal source

🌍Oct 23discoverynews.google.comTier 3 · Aggregated media

fda concerns unapproved glp-1 drugs retatrutide weight loss

BusinessWorld OnlineOriginal source

🌍Oct 23discoverynews.google.comTier 3 · Aggregated media

fda approved weight loss drug 2023

BusinessWorld OnlineOriginal source

🇯🇵Oct 23Researchjsmo.or.jpTier 2 · Direct publisher

【ご案内】ASCO Breakthrough 2027

Japanese Society of Medical OncologyOriginal source

🌍Oct 23discoverynews.google.comTier 3 · Aggregated media

fda approves new weight loss drug

BusinessWorld OnlineOriginal source

🌍Oct 23discoverynews.google.comTier 3 · Aggregated media

Hanmi's 1st Korean-developed GLP-1 obesity drug set for Oct. 29 launch: Yonhap

Korea Biomedical ReviewOriginal source

🌍Oct 23discoverynews.google.comTier 3 · Aggregated media

LabTurbo Biotech Corporation (7725.TWO) Analyst Insights, Price Targets & Recommendations - Yahoo Finance

Yahoo! Finance CanadaOriginal source

🌍Oct 23discoverynews.google.comTier 3 · Aggregated media

2026 fda approved weight loss drug retatrutide approval status

www.polskieradio.plOriginal source

🌍Oct 23discoverynews.google.comTier 3 · Aggregated media

Ascletis' Strategic Partner Sagimet Announces First Patient Dosed in Phase III U.S. Clinical Trial of Denifanstat (ASC40) for Moderate to Severe Acne

Yahoo FinanceOriginal source

🇯🇵Oct 23Industryotsuka.co.jpTier 3 · Secondary coverage

Otsuka Presents Landmark Final Phase 3 VISIONARY Results at ASN Demonstrating VOYXACT® (sibeprenlimab-szsi) Stabilized Kidney Function and Reduced Risk of Disease Progression and Kidney Failure, Redefining Treatment Paradigm in IgA Nephropathy

Otsuka Holdings RSSOriginal source

🇺🇰Oct 23Researchnature.comTier 2 · Direct publisher

AAV-mediated delivery of leptin but not adiponectin improves metabolic health in a pre-clinical mouse model of congenital generalised lipodystrophy

Nature Gene TherapyOriginal source

🇺🇸Oct 23Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities; Proposed Collection; Comment Request; Export Certificates for FDA Regulated Products

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on...

Federal RegisterOriginal source

🇺🇸Oct 23Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities; Proposed Collection; Comment Request; Product Jurisdiction and Combination Products

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on...

Federal RegisterOriginal source

🇺🇸Oct 23Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Accreditation Scheme for Conformity Assessment Program

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has b...

Federal RegisterOriginal source

🇺🇸Oct 23Regulatoryfederalregister.govTier 1 · Regulatory source

Determination of Regulatory Review Period for Purposes of Patent Extension; Correction of Notices-ANDEMBRY; ANZUPGO; ANKTIVA; BIZENGRI; BRINSUPRI; DAYVIGO

The Food and Drug Administration (FDA) is announcing corrections to the notices of Determination of...

Federal RegisterOriginal source

🇺🇸Oct 23Regulatoryfederalregister.govTier 1 · Regulatory source

Proposed Information Collection Activity; Child Care and Development Fund Plan Preprint for States/Territories for Federal Fiscal Year (FFY) 2028-2030 (ACF-118) and extension of Child Care and Development Fund Plan Preprint for States/Territories for FFY 2025-2027

The Administration for Children and Families (ACF) is requesting an extension without changes of the...

Federal RegisterOriginal source

🇺🇸Oct 23Regulatoryfederalregister.govTier 1 · Regulatory source

Center for Scientific Review; Notice of Closed Meetings

Federal RegisterOriginal source

🇺🇸Oct 23Regulatoryfederalregister.govTier 1 · Regulatory source

Center for Scientific Review; Amended Notice of Meeting

Federal RegisterOriginal source

🇺🇸Oct 23Regulatoryfederalregister.govTier 1 · Regulatory source

Questions and Answers Regarding Mandatory Cosmetics Recalls; Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance...

Federal RegisterOriginal source

🇺🇸Oct 23Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request: Advanced Nursing Education Program Specific Form OMB No. 0906-0089-Revision

In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Req...

Federal RegisterOriginal source

🇺🇸Oct 23Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request: National Practitioner Data Bank for Adverse Information on Physicians and Other Health Care Practitioners-45 CFR Part 60 Regulations and Forms, OMB No. 0906-0081-Revision

In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Req...

Federal RegisterOriginal source

🇺🇸Oct 23Regulatoryfederalregister.govTier 1 · Regulatory source

National Vaccine Injury Compensation Program; List of Petitions Received

HRSA is publishing this notice of petitions received under the National Vaccine Injury Compensation...

Federal RegisterOriginal source

🇺🇸Oct 23Regulatoryfederalregister.govTier 1 · Regulatory source

HHS Approval of Entities That Certify Medical Review Officers

This notice publishes a list of HHS approved Medical Review Officers (MROs) certification entities....

Federal RegisterOriginal source

🇺🇸Oct 23Regulatoryfederalregister.govTier 1 · Regulatory source

Action Levels for Cadmium in Processed Food Intended for Babies and Young Children; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of a draft...

Federal RegisterOriginal source

🇺🇸Oct 23Regulatoryfederalregister.govTier 1 · Regulatory source

Hazard Analysis and Risk-Based Preventive Controls for Human Food; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of one addi...

Federal RegisterOriginal source

🇺🇸Oct 23Regulatoryfederalregister.govTier 1 · Regulatory source

Request for Public Comment: 60-Day Notice for Reinstated Collection: Division of Urban Indian Affairs Uniform Data System and Budget Formulation

In compliance with the Paperwork Reduction Act of 1995, the Indian Health Service (IHS) invites the...

Federal RegisterOriginal source

🇺🇸Oct 23Researchreporter.nih.govTier 2 · Direct publisher

NIH award: Pharmacological Approaches for Transepithelial Delivery of Therapeutics to the Vocal Folds

Recipient: TEXAS CHRISTIAN UNIVERSITY. Award amount: 94340.

NIH RePORTEROriginal source

🇺🇸Oct 23Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Oxcarbazepine

Official structured record identifier: e46d4654-76bc-4c33-ac2b-e89ae11b7697.

openFDA Drug LabelsOriginal source

🇺🇸Oct 23Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Carbamazepine

Official structured record identifier: 7c1dd8ce-c490-40b4-b17a-da331df24cba.

openFDA Drug LabelsOriginal source

🇺🇸Oct 23Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Sertraline HCl

Official structured record identifier: 623b9672-b41e-4ec9-b2cc-f5bb383c39ba.

openFDA Drug LabelsOriginal source

🇺🇸Oct 23Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: LAXATIVE

Official structured record identifier: 5a65d4ab-447f-42bb-b38d-070db523b806.

openFDA Drug LabelsOriginal source

🇺🇸Oct 23Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: CVS Diphenhydramine Hydrochloride

Official structured record identifier: 3d71d306-893a-e73a-e063-6394a90a0a3b.

openFDA Drug LabelsOriginal source

🇺🇸Oct 23Researchnewsroom.clevelandclinic.orgTier 2 · Direct publisher

Newsweek Ranks Cleveland Clinic Among World's Best Smart Hospitals

Cleveland Clinic Main CampusOriginal source

🇪🇺Oct 23Researcheuropepmc.orgTier 2 · Direct publisher

History of gastrointestinal symptoms with other glucose‐lowering agents is associated with gastrointestinal adverse events after imeglimin initiation: A retrospective real‐world study

Europe PMCOriginal source

🇪🇺Oct 23Researcheuropepmc.orgTier 2 · Direct publisher

Opioid-Free versus Opioid-Based Anesthesia for Quality of Recovery After Knee Arthroscopy: A Randomized Non-Inferiority Trial.

Europe PMCOriginal source

🇪🇺Oct 23Researcheuropepmc.orgTier 2 · Direct publisher

Low-Dose Epidural Hydromorphone as an Adjunct to Ropivacaine for Intraoperative Visceral Traction Pain During Elective Cesarean Delivery: A Randomized, Double-Blind, Placebo-Controlled Trial.

Europe PMCOriginal source

🇪🇺Oct 23Researcheuropepmc.orgTier 2 · Direct publisher

Adjunctive Oliceridine During Propofol or Ciprofol Sedation for Same-Session Bidirectional Endoscopy in Older Adults: A Multicenter Randomized 2×2 Factorial Trial.

Europe PMCOriginal source

🇪🇺Oct 23Researcheuropepmc.orgTier 2 · Direct publisher

Clinical Evaluation of Biased μ-Opioid Receptor Agonists: A Narrative Comparative Review from Oliceridine to Tegileridine and Mechanistic Reappraisal.

Europe PMCOriginal source

🇪🇺Oct 23Researcheuropepmc.orgTier 2 · Direct publisher

A novel injectable drug-combination nanoparticle containing three antiretrovirals designed for HIV treatment: A first-in-human trial.

Europe PMCOriginal source

🇪🇺Oct 23Researcheuropepmc.orgTier 2 · Direct publisher

Letter: Paclitaxel- versus limus-coated balloons in the treatment of ISR.

Europe PMCOriginal source

🇪🇺Oct 23Researcheuropepmc.orgTier 2 · Direct publisher

Biolimus- versus sirolimus-eluting stents in percutaneous coronary intervention: a comprehensive systematic review and meta-analysis of randomised controlled trials.

Europe PMCOriginal source

🇪🇺Oct 23Researcheuropepmc.orgTier 2 · Direct publisher

Real-world Data to Assess the Applicability of Randomized Controlled Trials in Newly Metastatic Prostate Cancer.

Europe PMCOriginal source

🇪🇺Oct 23Researcheuropepmc.orgTier 2 · Direct publisher

Double-blind, placebo-controlled randomised clinical trial on flexible doses of escitalopram and naltrexone in the treatment of men with compulsive sexual behaviour disorder: study protocol presentation.

Europe PMCOriginal source

🇪🇺Oct 23Researcheuropepmc.orgTier 2 · Direct publisher

Rational design of PROTACs empowered by deep generative modeling: current advances and future perspectives.

Europe PMCOriginal source

🇪🇺Oct 23Researcheuropepmc.orgTier 2 · Direct publisher

From Robots to Organizations: The Role of the AI Scientist.

Europe PMCOriginal source

🇪🇺Oct 23Researcheuropepmc.orgTier 2 · Direct publisher

Data-Rich But Integration-Poor Human Trials: Conceptual Framework for Closing the AI Transformation Gap in Dietary Intervention and Cosmetic Human Trials.

Europe PMCOriginal source

🇪🇺Oct 23Researcheuropepmc.orgTier 2 · Direct publisher

Search for the glycated hemoglobin target minimizing mortality among people with type 2 diabetes with rare incidence of treatment-related severe hypoglycemia - Epidemiologic analysis of J-DOIT3 randomized controlled trial.

Europe PMCOriginal source

🇪🇺Oct 23Researcheuropepmc.orgTier 2 · Direct publisher

Ataxia Therapeutics: A Comprehensive Overview of the Clinical Development Pipeline.

Europe PMCOriginal source

🇪🇺Oct 23Researcheuropepmc.orgTier 2 · Direct publisher

Investigator-Initiated Trials as a Clinical Development Approach for Orphan Drugs Compared with Industry-Sponsored Trials in Japan.

Europe PMCOriginal source